Global Leading Market Research Publisher QYResearch announces the release of its latest report “Starch-based Micropellet Cores – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Starch-based Micropellet Cores market, including market size, share, demand, industry development status, and forecasts for the next few years.
Addressing core industry needs: Controlled-release oral formulations require biodegradable, biocompatible pellet cores – but synthetic polymers may have safety or regulatory concerns. Starch-based micropellet cores solve this with natural starch offering excellent biodegradability, moldability, and gastrointestinal safety. Key drivers include clean-label excipient demand, generic extended-release drugs, and natural polymer preference.
The global market for Starch-based Micropellet Cores was estimated to be worth US$ 84 million in 2025 and is projected to reach US$ 123 million, growing at a CAGR of 5.7% from 2026 to 2032. In 2024, global production is approximately 11,005 tons, with an average price of US$ 7,360 per ton.
The Starch-based Micropellet Core is a drug carrier made primarily from starch, widely used in the formulation of oral medications, particularly in sustained-release or controlled-release preparations. Starch offers excellent biodegradability and good moldability, making it an ideal material for micropellet cores. By encapsulating the active pharmaceutical ingredient (API) in the starch micropellet, the drug can be released gradually, ensuring prolonged therapeutic effects and reducing side effects. Furthermore, as a natural polymer, starch has good biocompatibility, allowing safe drug release in the gastrointestinal tract, generally without causing adverse reactions.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6098150/starch-based-micropellet-cores
Market Segmentation & Key Players
The Starch-based Micropellet Cores market is segmented as below:
Leading Suppliers: Colorcon, JRS, FREUND Corp, NB Entrepreneurs, Meenaxy Pharma Private Limited, Anhui Sunhere Pharmaceutical Excipients, Asahi Kasei Chemicals, Yuekang Pharmaceutical Group, Hangzhou Gaocheng Biotech & Health, Jiangsu Dongsheng Pharmaceutical Technology, Hainan Poly Pharm.
Segment by Type: Particle Size Below 500 μm | Particle Size 500–1000 μm | Particle Size Above 1000 μm
Segment by Application: Tablet | Capsule
Exclusive Industry Insights
Discrete extrusion-spheronization process: Starch-based micropellet cores are manufactured via extrusion-spheronization – starch (typically corn, potato, or rice starch) is blended with API and excipients, wet-massed, extruded, and spheronized. Starch’s natural swelling properties aid in controlled drug release.
Technical differentiation – particle size segments:
- Below 500 μm (15% revenue): Fine pellets for fast-disintegrating multi-particulate capsules. For pediatric/geriatric use.
- 500–1000 μm (65% revenue): Standard range, optimal for sustained-release coatings. Largest segment.
- Above 1000 μm (20% revenue): Large pellets for high-dose extended-release. Fastest-growing (CAGR 6.2%).
Recent 6-month data (Oct 2025 – Mar 2026):
- Tablet application dominates (66% revenue) – compressed multi-particulate tablets.
- Capsule application fastest-growing (CAGR 6.2%) – multi-particulate capsules.
- Modified starch grades (cross-linked, pregelatinized) for controlled release grew 15% YoY.
User case – Nutraceutical manufacturer (US, 50 tons/year): Developing sustained-release vitamin formulation using starch-based micropellet cores (500–700μm) achieved 12-hour extended release, improving patient compliance. Natural starch excipient enabled “clean label” marketing claim. Production cost: US$ 7.40/kg; premium pricing achieved (US$ 18/kg vs. synthetic US$ 12/kg).
Application insights: Tablet (66%) – MUPS tablets, disintegrating tablets, matrix tablets. Capsule (34%) – multi-particulate capsules, sprinkle capsules.
Critical performance requirements:
- Sphericity: Aspect ratio <1.2 for uniform coating.
- Swelling index: 10–30% for controlled release.
- Friability: <0.5% weight loss.
- Enzymatic degradation: Consistent in GI tract.
Regional snapshot: North America leads with 44% revenue share (clean-label demand). Europe holds 28% (natural excipient preference). Asia-Pacific fastest-growing (CAGR 6.5%), driven by generic drug manufacturing.
Conclusion
The starch-based micropellet cores market grows steadily, driven by natural excipient demand, sustained-release formulations, and clean-label trends. Success depends on sphericity control, modified starch grades, and batch-to-batch consistency. The projected US$ 123 million market by 2032 appears achievable.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
